Criado Scholz, Enrique – Trademark Portfolio
Entity Type: 99
Criado Scholz, Enrique holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include IVF AT HOME, FERTILITY AT HOME, and OVOBANK U.S. THE FIRST EUROPEAN DONOR EGG BANK. The owner is based in Marbella.
Avenida Severo Ochoa nº 67
Marbella 29600 , ES
Showing of trademarks Trademarks
Trademark Classifications
Criado Scholz, Enrique's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Criado Scholz, Enrique have?
Criado Scholz, Enrique has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.
What trademark classes does Criado Scholz, Enrique file in?
Criado Scholz, Enrique files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services), Class 40 (Treatment & Processing). Class 35 covers advertising; business management; business administration; office functions.
What are Criado Scholz, Enrique's most well-known trademarks?
Criado Scholz, Enrique's registered trademark portfolio includes well-known marks such as IVF AT HOME, FERTILITY AT HOME, and OVOBANK U.S. THE FIRST EUROPEAN DONOR EGG BANK. These are among 3 currently registered trademarks in the portfolio.
What is Criado Scholz, Enrique's trademark registration success rate?
Criado Scholz, Enrique has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.